Monday, September 13, 2021
8:12 AM EST – NeonMind Biosciences Inc. : Announced it has completed the sale of assets related to its consumer division, including e-commerce operations and underlying functional food assets, as well as shares owned in Translational Life Sciences Inc. (“TLS”), for a combined consideration of approximately C$1.1 million plus a royalty. NeonMind Biosciences Inc. (C.NEON) shares were unchanged at 0.125.
Stocks in Play: NeonMind Biosciences Inc., Mon, 13 Sep 2021 08:27:07 EST